Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
HTRF Human LAG3/MHCII biochemical binding assay, 500 Assay Points
This immune checkpoint assay is designed to identify human LAG3/MHC II checkpoint inhibitors.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Product information
Overview
The lymphocyte activation gene-3 (LAG-3), selectively transcribed in human activated T and NK cells, encodes a ligand for major histocompatibility complex (MHC) class II molecules. When LAG3 is bound to MHC II, T cell response is suppressed. Checkpoint inhibitors blocking LAG3/MHC II complex formation are generating considerable interest in cancer immunotherapy.
Specifications
| Assay Points |
500
|
|---|---|
| Assay Technology |
HTRF
|
| Brand |
HTRF
|
| Quantity |
1
|
| Shipping Conditions |
Shipped in Dry Ice
|
| Therapeutic Area |
Oncology & Inflammation
|
| Unit Size |
500 Assay Points
|
Video gallery
Resources
This guide provides you an overview of HTRF applications in several therapeutic areas.
SDS, COAs, Manuals and more
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
-
LanguageEnglishCountryUnited States
-
LanguageFrenchCountryFrance
-
LanguageGermanCountryGermany
-
LanguageGreekCountryGreece
-
LanguageItalianCountryItaly
-
LanguageSpanishCountrySpain
-
LanguageEnglishCountryUnited Kingdom
-
Lot number03CLot dateJuly 3, 2026
-
Lot number03BLot dateJune 19, 2025
-
Lot number02ALot dateJune 7, 2025
-
Lot number03ALot dateMay 6, 2025
-
Lot number02BLot dateMay 6, 2025
-
Resource typeManualLanguageEnglishCountry-
How can we help you?
We are here to answer your questions.
